GynQura Therapeutics
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$2.83M
Company Overview
GynQura Therapeutics is a biotechnology company developing non-hormonal, disease-modifying therapies for endometriosis using a patient-derived organoid platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GynQura Therapeutics Comparables
Compare GynQura Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclana Bio | 87% | |
| Rosebud Biosciences | 70% | |
| EndoGene.Bio | 66% |
GynQura Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Accelerator | Jan 23, 2024 |
GynQura Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Foundation | Grant |
| BioInnovation Institute | Accelerator |
GynQura Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GynQura Therapeutics's valuation, stock price, and market status.
Is GynQura Therapeutics a public or private company?
GynQura Therapeutics is a private company.
What is the current stock price of GynQura Therapeutics?
GynQura Therapeutics is a private company with no public stock price. Caplight tracks GynQura Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is GynQura Therapeutics worth (valuation)?
Valuation information for GynQura Therapeutics is not publicly available.
Can I buy GynQura Therapeutics stock?
GynQura Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GynQura Therapeutics's last funding round?
GynQura Therapeutics's most recent funding round was Grant on August 14, 2025.
Who are the main investors in GynQura Therapeutics?
Key investors in GynQura Therapeutics include EQT Foundation, BioInnovation Institute.
Will GynQura Therapeutics IPO soon?
No public IPO plans have been announced for GynQura Therapeutics.
How can I track GynQura Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GynQura Therapeutics's secondary market activity and sign up for updates.